Author

Natascha Franz

Max Planck Institute for Medical Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdinasir Adow· 1 shared Andreas Zingg· 1 shared Birgit KochiD· 1 shared Christoph SchultheißiD· 1 shared Claudia Fischer· 1 shared De‐en SuniD· 1 shared Heinz Philipp LaubliiD· 1 shared Jonas WilhelmiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Abdinasir Adow

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A high-affinity split-HaloTag for live-cell protein labeling

Yin‐Hsi Lin, Julian Kompa, De‐en Sun, Runyu Mao, Birgit Koch, Konstantin Hinnah, Jonas Wilhelm, Natascha Franz, Stefanie F. Kühn, Tanja Menche, Abdinasir Adow, Paula Breuer, Julien Hiblot, Kai Johnsson

This paper introduces a high-affinity split-HaloTag system for live-cell protein labeling, enabling efficient and versatile imaging with compatibility for advanced microscopy techniques.

Nature Communications · Mar 25, 2026Peer-reviewedBiochemistry

CAR T cell engineering impacts antigen-independent activation and co-inhibition

Simon Stücheli, Christoph Schultheiß, Paul Schmidt-Barbo, Andreas Zingg, Natascha Franz, Sarah Adamo, Claudia Fischer, Heinz Philipp Laubli, Mascha Binder

This study compares viral and non-viral methods for CAR T cell engineering, finding that non-viral SB transposition alters T cell activation and co-inhibition markers, with CAR design and donor type influencing outcomes.

bioRxiv · Jan 20, 2025 · PreprintImmunology